Joan Bladé

53.8k citations
328 papers · 15.1k · 4 hit papers · h-index 61

Impact in

  • Hematology top 0.01%
    • Multiple Myeloma Research and Treatments
  • Oncology top 0.2%
    • Peptidase Inhibition and Analysis
    • Cancer Treatment and Pharmacology

Papers in

    • Multiple Myeloma Research and Treatments 265
    • Protein Degradation and Inhibitors 70
    • Amyloidosis: Diagnosis, Treatment, Outcomes 46

Joan Bladé

318 papers receiving 14.8k citations

Joan Bladé's Hit Papers

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma 2013 · 353 citations
3530+9+18Years since publication50010001.5k

Peers

Joan Bladé
Comparison fields: 5 of 119
  • Hematology 11.8k
  • Oncology 5.5k
  • Genetics 1.9k
  • Molecular Biology 7.7k
  • Pathology and Forensic Medicine 806
Replace David S. Siegel with:
David S. Siegel United States
Michèle Cavo Italy
A. Keith Stewart United States
Thierry Façon France
Jean‐Luc Harousseau France
Michel Attal France
María‐Victoria Mateos Spain
Xavier Leleu France
Mario Boccadoro Italy
Francis K. Buadi United States
Joan Bladé relative to David S. Siegel United States David S. Siegel's profile →
Citations per field
00.5×1.5×
David S. Siegel · 1×
Citations per year

Countries citing papers authored by Joan Bladé

Since Specialization
Citations

This map shows the geographic impact of Joan Bladé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Bladé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Bladé more than expected).

Fields of papers citing papers by Joan Bladé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Bladé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Bladé. The network helps show where Joan Bladé may publish in the future.

Co-authors

The 25 scholars most cited alongside Joan Bladé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joan Bladé Line = papers co-authored together Joan Bladé links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 328 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International Staging System for Multiple Myeloma
Hit paper breakdown →
20051978
2
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
Hit paper breakdown →
19981192
3
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Hit paper breakdown →
2007506
4
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Hit paper breakdown →
2013353
5 1998279
6 2008258
7 2011243
8 2008239
9 2005235
10 2009233
11 1995222
12 2008218
13 1999212
14 2011198
15 2008193
16 2008173
17
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
1998172
18 2009167
19 2018159
20 2010159

About Joan Bladé

Joan Bladé is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 328 papers that have together received 15.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (265 papers), Protein Degradation and Inhibitors (70 papers), Cancer Treatment and Pharmacology (56 papers), Peptidase Inhibition and Analysis (51 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (46 papers), Chronic Lymphocytic Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers) and HIV/AIDS drug development and treatment (18 papers). The work is most often cited by research in Hematology (11.8k citations), Oncology (5.5k citations), Genetics (1.9k citations), Molecular Biology (7.7k citations) and Pathology and Forensic Medicine (806 citations). Joan Bladé has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Laura Rosiñol, Jesús F. San Miguel, Robert A. Kyle, Pieter Sonneveld, Juan José Lahuerta, María Teresa Cibeira, Heinz Ludwig, Mario Boccadoro, Philip R. Greipp and Carlos Fernández de Larrea. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact